AlphaYouKURA: Leoni Mollie discloses a sale
By AlphaYouPublished Form 4
Leoni Mollie
Reporting filer
Leoni Mollie reported Sale in Kura Oncology, Inc.: 12448 units of Common Stock, dated 2026-09-28. The full Form 4 contains 2 transaction entries.
- Disclosed
- Sep 29, 2026
Reported details
2 entries| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Leoni Mollie | 2026-09-28 | S | Sale | 12448 | 10.4973 | 169,897 | 1 day | Filed terms
|
| Common Stock | Leoni Mollie | 2026-09-29 | S | Sale | 28802 | 10.7481 | 141,095 | 0 days | Filed terms
|
Common Stock
- Owner
- Leoni Mollie
- Date
- 2026-09-28
- Code
- S
- Action
- Sale
- Quantity
- 12448
- Price
- 10.4973
- Following holdings
- 169,897
- Reporting delay
- 1 day
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-09-28
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: false
- id: F1
- transaction Shares: 12448
- transaction Price Per Share: 10.4973
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 169897
- direct Or Indirect Ownership: D
Common Stock
- Owner
- Leoni Mollie
- Date
- 2026-09-29
- Code
- S
- Action
- Sale
- Quantity
- 28802
- Price
- 10.7481
- Following holdings
- 141,095
- Reporting delay
- 0 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-09-29
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: false
- id: F2
- transaction Shares: 28802
- transaction Price Per Share: 10.7481
- id: F3
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 141095
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Leoni Mollie: Chief Medical Officer.
- The filing reports a Rule 10b5-1 trading plan.
- F1: Sell-to-cover for taxes associated with the vesting of 1/6th of the underlying shares of performance-based restricted stock units ("PSUs") granted to the Reporting Person on May 31, 2023. Each PSU represents the contingent right to receive one share of the Issuer's common stock based on the achievement of each of three specified development milestones, and the one-year anniversary of each milestone achievement, subject to the Reporting Person's continuous service on each corresponding vesting date. The one-year anniversary of the specified development milestone was determined to be met on September 27, 2026, resulting in the vesting of 1/6th of the underlying shares.
- F2: The shares sold were acquired by the Reporting Person upon vesting of performance restricted stock units on September 27, 2026. The sales reported herein were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 19, 2026.
- F3: This transaction was executed in multiple trades at prices ranging from $10.53 to $10.89. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Original sources
Prepared automatically from public filing data. Report a correction.